FRANKFURT (Reuters) -Swiss drugmaker Roche has abandoned global targets for a more diverse workforce to avoid penalties from ...

Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse ...

Swiss pharmaceutical giant Roche is cutting its global diversity workforce targets, aligning with recent U.S. legal changes ...

With DEI programs facing greater scrutiny, adopting a global hiring strategy can be a better way to access diverse, qualified ...

Korean entertainment powerhouse CJ ENM, the studio behind Oscar-winning “Parasite,” is intensifying its strategy to expand ...

Roche Holding AG scrapped long-held global diversity targets for its leadership, showing how pressure from the Trump administration is causing companies to back away from DEI policies outside the US.

Jena McGregor, editorial director of Modern Executive Solutions, on the global dilemma that is troubling CHROs.

Swiss pharmaceutical giants Roche and Novartis are revising their diversity policies in response to recent U.S. executive ...

Boardrooms are under increasing pressure - from lawyers as well as staff - to work out how to tread the DEI tightrope.

Gather25 reflects our desire to sing together but also the struggle to capture the diverse sounds of the church around the ...

CGTN published an article on the second anniversary of China's Global Civilization Initiative proposed by Chinese President Xi Jinping, which has ...